The FDA has approved a once-weekly therapy to improve growth for children aged 2 years and older with achondroplasia, according to an industry press release.Navepegritide (Yuviwel, Ascendis Pharma), a ...
The Hechinger Report on MSN
Are microschools a solution to falling public school enrollment? One district thinks so
GREENFIELD, Ind. — Seventh grader Taitym Lynch plans most of her school day herself, mapping out a schedule each morning on her school laptop. She typically starts with math when her brain is sharpest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results